057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs

057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) Vol. 58; no. Supplement_3
Main Authors: van Vollenhoven, R, Dore, R, Chen, K, Camp, H S, Enejosa, J, Shaw, T, Suboticki, J L, Hall, S
Format: Journal Article
Language:English
Published: Oxford University Press 01-04-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/kez106.056